The Trump administration is reportedly planning to create a political board with veto power over which biomedical research the federal government funds, because apparently cancer doesn't already have enough obstacles. The executive order, reported by the Washington Post and Politico, would let senior administration officials kill NIH grants that don't line up with the president's ideological agenda. The world's largest public funder of biomedical research would answer to the guys who brought you the Lafayette Square photo-op.
How This Would Actually Work
According to the Washington Post, Russell Vought, director of the Office of Management and Budget, proposed the order during a Friday meeting where senior administration officials accused the NIH of funding "woke" initiatives. The language alone should tell you everything about the intellectual seriousness on display here.
The board would include Vought and NIH director Jay Bhattacharya, according to Politico, and would be required to reach unanimous decisions before grants could go forward. Unanimous. So a single political appointee could spike decades of research into, say, HIV transmission or childhood cancer treatment, because the grant proposal contained the word "equity."
That is not a hypothetical. The Guardian reports that the Trump administration has already been flagging research containing keywords like "equity," "racist," "gender," and "climate change" to block scientific funding. They built a blacklist. For science words.
What NIH Actually Does and Why This Matters
The NIH is not a fringe agency. It is the world's largest public funder of biomedical research. It has been responsible for foundational work on vaccines, cancer treatments, HIV antiretrovirals, and basically every major medical advance you have benefited from in your lifetime. It operates on peer review, meaning proposals get evaluated by scientists with relevant expertise on the basis of scientific merit. That is the whole system.
What Trump's order would do, as the Guardian reports, is replace scientific merit with political compliance. The question would no longer be "is this rigorous, promising research?" It would be "does Jay Bhattacharya and Russell Vought both sign off on this?" Russell Vought, to be clear, is a budget director whose scientific credentials consist of wanting to spend less money on science.
Bhattacharya, to his partial credit, reportedly pushed back. The Guardian notes that he has resisted cuts to federal research spending and defended the NIH's grant-making process during the Friday meeting, while Vought made clear he wants to reshape how federal dollars flow. When the NIH director is the moderate voice in the room, things have gotten genuinely strange.
Billions Already Cut Before This Order Even Exists
This is not the administration's first swing at gutting scientific research. Since Trump returned to office, the Guardian reports that billions of dollars in federal grants related to health, nutrition, the environment, and disaster relief have been cut or frozen. Not trimmed. Billions.
Researchers have not sat quietly. The NIH is currently facing a class-action lawsuit from scientists who argue the administration is terminating grants specifically to silence viewpoints the president dislikes. The lawsuit makes a First Amendment argument, and it is not a frivolous one. "What the First Amendment does not allow is the government's use of its funding power to target or silence the expression of disfavored viewpoints within the biomedical research community," the suit reads.
That case was already working its way through the courts when the administration decided the logical next step was to formalize the political veto process with an executive order. Bold strategy.
The 'Woke Science' Accusation, Examined
Let's sit with the "woke" framing for a moment, because it is doing a lot of work here. The administration's position, as described in the Washington Post's reporting, is that the NIH has been funding initiatives that go against Trump's political priorities. That is the accusation. Not that the science is bad. Not that the grants are wasteful. That the research does not align with the president's agenda.
This is the crux of the whole argument. Science, by design, does not align with anyone's agenda. That is the point. A study on how poverty affects health outcomes is not "woke." A study on racial disparities in maternal mortality is not an ideological attack. These are research questions with measurable answers. The administration's complaint is that it does not like what the answers might be.
The Department of Health and Human Services and the White House did not respond to requests for comment, per the Guardian. Genuinely surprised.
The Dingo Take
You are supposed to believe this is about fiscal responsibility and eliminating waste. That is the framing the administration would prefer. But the tell is in the mechanism they chose. If this were about saving money, you would hire more auditors. You would not build a unanimity-required political board where a budget director can personally veto grants for containing the word "gender." That is not efficiency. That is control.
The NIH has produced some of the most consequential science in human history precisely because politicians stayed out of the peer review process. The moment you make grant funding contingent on ideological compliance, you do not just defund the research you dislike. You chill every researcher who has to decide whether their next proposal is too risky to submit. The chilling effect is the point. You do not need to veto everything if applicants start self-censoring before they even apply.
And here is the part that should keep you up at night. The diseases these researchers study do not care about Russell Vought's politics. Cancer does not check whether your grant used a flagged keyword. HIV does not pause while the board reaches unanimous consensus. The consequences of politicizing this research will show up years from now, in treatments not developed and outbreaks not prevented, long after everyone who signed this executive order has moved on to their next grift. That is the real cost. It just won't be on anyone's balance sheet.
Comments